News

SAN DIEGO, Nov. 28, 2022 /PRNewswire/ — Neurelis, Inc., a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and orphan neurologic disorders characterized by high unmet medical […]

SAN DIEGO, Nov. 28, 2022 /PRNewswire/ – Greenbutts, a science-driven leader in biodegradable filter technology, announces a jointly patent-protected new technology with world-renowned Boegli Gravures S.A. The newly filed intellectual property, trademarked as “Greenbossing”, comes […]

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive presentation at the Emerging Growth Conference. SAN DIEGO, Nov. 28, 2022 /PRNewswire/ — Regen BioPharma, Inc. […]

Days after adding some finance, dealmaking and technical talent to the top team, Escient Pharma has taken the wraps off a $120 million round to go broader in the clinic. New Enterprise Associates, Abingworth and […]

SAN DIEGO, Nov. 28, 2022 /PRNewswire/ — On December 2, the Lennox-Gastaut Syndrome (LGS) Foundation will host its LGS Research Roundtable at the American Epilepsy Society’s (AES) annual meeting in Nashville, TN. The event will […]

SAN DIEGO, Nov. 28, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the United States […]

Visage is working with AWS to streamline and further accelerate access to imaging data with Amazon HealthLake Imaging SAN DIEGO, Nov. 27, 2022 /PRNewswire/ — Visage Imaging, Inc. (“Visage”), a wholly owned subsidiary of Pro […]

SAN DIEGO, Nov. 25, 2022 /PRNewswire/ — With the launch of Season 4 of Living Room Wisdom with Patrina Wisdom in January 2023, Patrina has carved out a space for women to talk about their […]

Dexcom’s program spotlights college athletes with diabetes to inspire others living with the disease to keep playing sports Click here to view original post

New Light Technologies Inc. (NLT) will develop, together with researchers from the University of California, San Diego (UC San Diego), a Dynamic Infectious Disease Risk Platform to provide decision-makers a data-driven predictive tool for early […]

The company partners with QURE and Curta to assess value of early identification in high-risk cohorts SAN DIEGO, Nov. 22, 2022 /PRNewswire/ — Biological Dynamics, an exosome-isolation technology and early disease detection diagnostic company, today […]

SAN DIEGO, Nov. 21, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet […]

UFC’s Top Lightweight Fighter, Paddy the Baddy, and Cage Warriors’ President Graham Boylan invest in the rapidly growing Southern California Combat Sports Brand SAN DIEGO, Nov. 21, 2022 /PRNewswire/ — The BXNG Club (BXNG), a […]

SAN DIEGO, Nov. 21, 2022 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate […]

SAN DIEGO and CALGARY, AB, Nov. 21, 2022 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the publication of two abstracts for poster presentations at the upcoming San Antonio Breast Cancer Symposium […]

VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis Ainos advances its product pipeline as it targets commencing clinical studies during the second quarter of 2023 […]

Early-stage company developing diagnostic solutions to revolutionize early detection of cancer and other diseases SAN DIEGO and SILICON VALLEY, Calif., Nov. 18, 2022 /PRNewswire/ — Silicon Catalyst, the world’s only incubator focused exclusively on accelerating […]

TOKYO & SAN DIEGO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology and MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company […]